Description

Cibor (bemiparin sodium) 2500 Solution for Injections 12500ME/ml Syringe 0.2 ml №10

Ingredients:

Each 0.2 ml syringe contains 12500 IU of bemiparin sodium as the active ingredient.

Dosage:

The recommended dosage is determined by a healthcare professional based on the patient’s condition. It is typically administered subcutaneously once a day.

Indications:

Cibor is indicated for the prevention of venous thromboembolism in patients undergoing surgery. It is also used for the treatment of deep vein thrombosis and pulmonary embolism.

Contraindications:

Do not use Cibor if you have a history of heparin-induced thrombocytopenia or hypersensitivity to bemiparin sodium. It should be used with caution in patients with a high risk of bleeding.

Directions:

Administer the injection subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites and do not massage the area after administration.

Scientific Evidence:

Bemiparin sodium, the active ingredient in Cibor, is a low molecular weight heparin that exhibits anticoagulant properties by inhibiting the activity of factor Xa. Studies have shown that bemiparin sodium is effective in preventing thromboembolic events in surgical patients.

A study published in the Journal of Thrombosis and Haemostasis demonstrated the efficacy of bemiparin sodium in reducing the incidence of deep vein thrombosis following orthopedic surgery compared to unfractionated heparin.

Additional Information:

• Storage: Store Cibor injections at room temperature away from light and moisture.
• Side Effects: Common side effects may include bleeding at the injection site, bruising, or allergic reactions.